- Home
- PRG vs OPK Comparison
PRG vs OPK Comparison
Compare PRG & OPK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PRG
- OPK
- Stock Information
- Founded
- PRG 2020
- OPK 2007
- Country
- PRG United States
- OPK United States
- Employees
- PRG N/A
- OPK N/A
- Industry
- PRG Diversified Commercial Services
- OPK Biotechnology: Pharmaceutical Preparations
- Sector
- PRG Consumer Discretionary
- OPK Health Care
- Exchange
- PRG Nasdaq
- OPK Nasdaq
- Market Cap
- PRG 1.4B
- OPK 1.1B
- IPO Year
- PRG N/A
- OPK 1995
- Fundamental
- Price
- PRG $31.67
- OPK $1.52
- Analyst Decision
- PRG Hold
- OPK Buy
- Analyst Count
- PRG 6
- OPK 3
- Target Price
- PRG $35.50
- OPK $2.63
- AVG Volume (30 Days)
- PRG 446.2K
- OPK 2.4M
- Earning Date
- PRG 10-22-2025
- OPK 11-06-2025
- Dividend Yield
- PRG 1.65%
- OPK N/A
- EPS Growth
- PRG 109.72
- OPK N/A
- EPS
- PRG 5.11
- OPK N/A
- Revenue
- PRG $2,518,216,000.00
- OPK $664,029,000.00
- Revenue This Year
- PRG $1.44
- OPK N/A
- Revenue Next Year
- PRG $3.56
- OPK $0.97
- P/E Ratio
- PRG $6.18
- OPK N/A
- Revenue Growth
- PRG 5.17
- OPK N/A
- 52 Week Low
- PRG $23.50
- OPK $1.11
- 52 Week High
- PRG $50.12
- OPK $2.04
- Technical
- Relative Strength Index (RSI)
- PRG 43.13
- OPK 52.96
- Support Level
- PRG $30.07
- OPK $1.48
- Resistance Level
- PRG $32.10
- OPK $1.57
- Average True Range (ATR)
- PRG 0.88
- OPK 0.05
- MACD
- PRG -0.12
- OPK -0.01
- Stochastic Oscillator
- PRG 37.55
- OPK 47.22
About PRG PROG Holdings Inc.
PROG Holdings Inc is a financial technology holding company that provides transparent and competitive payment options to consumers. The company has two reportable segments: Progressive Leasing, an in-store, app-based, and e-commerce point-of-sale lease-to-own solutions provider; and Vive Financial (Vive), an omnichannel provider of second-look revolving credit products. The majority of the revenue of the company is earned through the Progressive Leasing segment.
About OPK OPKO Health Inc.
OPKO Health Inc is a diversified biotechnology company that operates pharmaceutical and diagnostic development programs. Its segments include pharmaceutical and diagnostics. The Pharmaceutical segment consists of its pharmaceutical operations in Chile, Mexico, Ireland, Israel, Spain, Ecuador, France, the United States, and its pharmaceutical research and development operations. The Diagnostics segment consists of clinical and genomics laboratory operations through BioReference and point-of-care operations. It generates the majority of its revenue from the Diagnostics segment.